Pluri Inc. (NASDAQ:PLUR) Short Interest Down 26.2% in July

Pluri Inc. (NASDAQ:PLUR) saw a significant decrease in short interest during the month of July. As of July 15th, there was short interest totalling 17,500 shares, a decrease of 26.2% from the June 30th total of 23,700 shares. Based on an average trading volume of 7,800 shares, the days-to-cover ratio is presently 2.2 days. Approximately 0.4% of the shares of the company are sold short.

Pluri Stock Performance

PLUR stock traded up $0.04 during trading on Friday, reaching $5.65. The stock had a trading volume of 3,738 shares, compared to its average volume of 5,415. The stock’s 50 day moving average is $5.66 and its two-hundred day moving average is $5.88. The firm has a market cap of $30.44 million, a PE ratio of -1.37 and a beta of 1.65. Pluri has a 52 week low of $3.45 and a 52 week high of $8.48. The company has a current ratio of 6.05, a quick ratio of 6.05 and a debt-to-equity ratio of 13.04.

Pluri (NASDAQ:PLUR) last issued its quarterly earnings data on Thursday, May 9th. The company reported ($1.01) earnings per share for the quarter. The business had revenue of $0.07 million during the quarter. Pluri had a negative return on equity of 248.48% and a negative net margin of 6,339.59%.

About Pluri

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.